Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3765197019 | Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3765198012 | Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3765199016 | Ethinyl estradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | This attribute specifies the denominator unit for the concentration strength of a product. | hour | true | Inferred relationship | Some | 2 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | This attribute specifies the numerator unit for the concentration strength of a product. | mcg | true | Inferred relationship | Some | 1 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator value | un | false | Inferred relationship | Some | 2 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator value | 1.46 | false | Inferred relationship | Some | 1 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | true | Inferred relationship | Some | ||
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Is a | Ethinylestradiol and norelgestromin only product in transdermal dose form | true | Inferred relationship | Some | ||
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Norelgestromin (substance) | true | Inferred relationship | Some | 2 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | This attribute specifies the numerator unit for the concentration strength of a product. | mcg | true | Inferred relationship | Some | 2 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator value | 6.25 | false | Inferred relationship | Some | 2 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | This attribute specifies the denominator unit for the concentration strength of a product. | hour | true | Inferred relationship | Some | 1 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Plays role | Contraceptive therapeutic role (role) | false | Inferred relationship | Some | ||
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Norelgestromin (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets